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Abstract The neuropathology of simian immunodeficiency
(SIV) infection in cynomolgus macaques (Macaca fascicu-
laris) was investigated following infection with either Tcell
tropic SIVmacJ5, SIVmacC8 or macrophage tropic
SIVmac17E-Fr. Formalin fixed, paraffin embedded brain
tissue sections were analysed using a combination of in situ
techniques. Macaques infected with either wild-type SIV-
macJ5 or neurovirulent SIVmac17E-Fr showed evidence of
neuronal dephosphorylation, loss of oligodendrocyte and
CCR5 staining, lack of microglial MHC II expression,
infiltration by CD4
+ and CD8
+ Tc e l l sa n dm i l da s t r o c y t o s i s .
SIVmacJ5-infected animals exhibited activation of microglia
whilst those infected with SIVmac17E-Fr demonstrated a loss
of microglia staining. These results are suggestive of impaired
central nervous system (CNS) physiology. Furthermore, infil-
tration by Tcells into the brain parenchyma indicated disrup-
tion of the blood brain barrier (BBB). Animals infected with
the Δnef-attenuated SIVmacC8 showed microglial activation
and astrogliosis indicative of an inflammatory response, lack
of MHC II and CCR5 staining and infiltration by CD8
+ T
cells. These results demonstrate that the SIV infection of
cynomolgus macaque can be used as a model to replicate the
range of CNS pathologies observed following HIV infection
of humans and to investigate the pathogenesis of HIVassoci-
ated neuropathology.
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Introduction
Neuropathology and symptoms of central nervous dis-
ease are late complications of HIV-1 infection and before
widespread use of antiretroviral therapies the most severe
form, HIV-1 associated dementia (HAD), developed in
20–30% of patients (Gonzalez-Scarano and Marin-Garcia
2005;K a u le ta l .2005). Despite the use of continually
advancing drug therapy regimes over the last two dec-
ades up to 40% of HIV-infected individuals still develop
a range of HIV-1 associated neurocognitive disorders
(HAND; Antinori et al. 2007) that can greatly affect
daily life and potentially disrupt adherence to their drug
regime.
HIV rapidly enters the central nervous system following
infection, probably transiting the blood brain barrier within
infected monocytes and lymphocytes (Liu et al. 2002;
Albright et al. 2003). The exact cause of the ensuing neu-
ronal damage is currently unknown but the potential exists
for both viral proteins and/or the resulting inflammatory
response to be the causative agent (Gonzalez-Scarano and
Marin-Garcia 2005; Kaul et al. 2005).
A pathology of HIV encephalitis (HIVE) can develop,
characterised by the presence of astrogliosis, microglial
nodules, accumulation of perivascular macrophages and
multinucleated giant cells (MNGC; Flaherty et al. 1997;
Overholser et al. 2003) and may be present despite very
low levels of viral replication within the CNS (Valcour et al.
2011).
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gories of HAND in 2007 (Antinori et al. 2007) variability in
how neuropsychological testing is performed in a busy or
under resourced clinical setting makes it difficult to follow
the development of HAND on an epidemiological scale. It is
therefore still a matter for debate whether the categories
of HAND define a pathway along which patients will
inevitable progress or whether they define distinct types
of neurocognitive disorders, the development of which
are determined by a combination of viral and host
factors.
The experimental infection of macaque species with
strains of SIV has been used for a number of years to
investigate pathology associated with HIV infection. Many
of the pathological characteristics observed in HAD and
HIVE have been found within SIV-infected macaque brains
(Desrosiers and Ringler 1989; Ringler et al. 1998; Sharer et
al. 1988). However, much of this work has been undertaken
using a combination of macaque species and macrophage
tropic virus strains designed to result in the rapid develop-
ment of disease and neurological pathology. For example, a
model developed by Zink et al. using pig-tailed macaques
(Macaca nemestrina) co-infected with SIVmac17E-Fr and
SIVmacDeltaB670 (Clements et al. 2002; Craig et al. 1997;
Zink et al. 1999) was developed to ensure that the maximal
numbers of infected animals developed rapid SIV-related
neurological complications. Whilst these models are valu-
able to investigate late stage neurological disease pathology
and to evaluate potential therapeutic interventions, rapid
disease development is not the prevalent phenotype in
humans (Williams et al. 2008). Furthermore, they are not
necessarily appropriate for research to establish the patho-
genesis of neuropathology. The availability of a model
exhibiting a more gradual disease development may prove
more suitable for investigating the early events that follow
SIV infection and identify opportunities for novel prophy-
lactic treatments that specifically prevent or control
neuropathology.
Compared with rhesus (Macaca mulatta) and pig tail
macaques, more limited information is available about the
ability of SIV to enter and cause pathology within the CNS
of cynomolgus macaques. The development of neuroviru-
lent lesions in small-scale studies has been reported follow-
ing infection with either the SIVmac17E-Fr-SIV/DeltaB670
combination (Zink et al. 1997) or various SIVsmm strains
(Baskerville et al. 1990; Li et al. 1991). Neuroinvasion of
the macrophage tropic SIVmac251 32H was associated with
a progressive loss of neuronal diameter (Montgomery et al.
1998) and progressive dendritic pathology (Montgomery et
al. 1999) whereas infection with the lymphotropic SIV-
mac239 resulted in an increase in neuronal diameter
(Montgomery et al. et al. 1998). Infection with neither virus
has been associated with the formation of an MNGC
pathology within the CNS, as is frequently reported in the
more pathogenic rhesus and pig-tail macaque models.
To understand the neuropathological consequences of
SIV infection of cynomolgus macaques and its relationship
with peripheral markers of viral replication, we undertook a
comparative study of CNS tissue collected from three
groups of cynomolgus macaques patently infected with
either T cell tropic wild-type SIVmacJ5 (Rud et al. 1994),
Δnef attenuated SIVmacC8 (Rud et al. 1994) or with mac-
rophage tropic SIVmac17E-Fr (Flaherty et al. 1997). Evi-
dence of SIV infection was detected in samples of brain
from all macaques analysed. However, distinct patterns of
neuropathology were associated with each virus. These data
indicate that SIVenters the brains of cynomolgus macaques
even when there is limited viral infection detectable in the
blood. These models may be valuable to study SIV neuro-
pathological events that occur prior to or in the absence of
clinical neurological disease and following infection with
SIV strains that are representative of a range of peripheral
viral replication levels.
Materials and methods
Animals
Purpose bred juvenile, SRV-ve and STLV-ve cynomolgus
macaques were used in these studies. The animals were
housed and maintained in accordance with Home Office
guidelines for care and maintenance of non-human primates.
Animals were sedated with ketamine hydrochloride (Vetalar
V, Pharmacia Animal Health Ltd, Corby, UK) before inoc-
ulation of virus or sampling of blood by venepuncture. On
each of these occasions, sedated macaques were weighed
and inspected for general health and signs of disease. At the
end of the study, macaques were killed humanely by an
overdose of anaesthetic.
Virus
SIVmacJ5 and SIVmacC8 were derived by molecular clon-
ing from the 11/88 pool of SIVmac32H as previously
described(Rudetal.1994).SIVmacC8isgeneticallyidentical
with SIVmacJ5 except for an in-frame 4 amino acid deletion
in Nef, 2 other conservative amino acid changes in Nef and a
smallnumberofnucleotidechangesintheU3’LTR region not
associated with currently known functional motifs. SIV-
macC8 exhibits an attenuated phenotype in rhesus and cyn-
omolgus macaques (Almond et al. 1995; Cranage et al. 1997;
Clarke et al. 2003). SIVmac17E-Fr was derived from SIV-
mac239aspreviouslydescribed (Flahertyetal.1997)andwas
kindly provided by JE Clements (Johns Hopkins School of
Medicine, Baltimore).
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Two groups of four animals were inoculated intravenously
with either 5×10
3 TCID50 SIVmacC8 (group A, W250-
W253) or 5×10
3 TCID50 SIVmacJ5 (group B, W254-
W257). 20 weeks following this initial inoculation, both
groups were challenged with 50 TCID50 SIVmac17E-Fr. A
third group of SIV naive animals (group C, X69-X72) were
also challenged with SIVmac17E-Fr at this point to
provide a challenge control group. Groups A, B and C
were euthanized 23 weeks after SIVmac17E-Fr chal-
lenge and a number of tissue samples including the
entire brain and brain stem collected at necropsy for
analysis. Equivalent brains taken at necropsy from SIV
naïve juvenile macaques were used to establish baseline
levels of staining within SIV negative tissues. Groups
consisted of animals of either sex.
Virological assessments
SIV viral RNA loads were determined in plasma samples
collected at various times throughout the course of the study
by quantitative real-time reverse transcriptase PCR, as
described previously (Berry et al. 2008). Differential nef spe-
cific DNA PCR and restriction endonuclease analyses were
performed to distinguish SIVmac17E-Fr from SIVmac J5 or
SIVmacC8. Following nested PCR amplification of the nef
gene SIVmacC8 and SIVmacJ5 were differentiated by Rsa1
digestion (Rose et al. 1995) and a further restriction digest
with Nsi 1 to differentiate SIV17E-Fr from SIVmacC8 and
SIVmacJ5
T cell and platelet analyses
The presence and proportion of CD4
+ and CD8
+ cells in
peripheral blood was determined by an immunostaining
technique involving antibodies directly conjugated to fluo-
rochromes as described previously (Stebbings et al. 2002).
Platelet levels were determined by processing whole
peripheral blood through a Beckman Coulter AcT. 5 diff
haematology analyser and comparing against Coulter Act. 5
diff Control Plus standard samples.
Tissue preparation
Whole brains were harvested post mortem and fixed in 10%
(v/v) formal saline for 4 weeks at 4°C. Formalin fixed brains
were then dissected into the following sections: frontal lobe,
parietal lobe, temporal lobe, occipital lobe, thalamus,
midbrain, pons, medulla oblongata and cerebellum prior
to embedding in paraffin wax using standard histologi-
cal procedures. Four micron sections were cut from
each embedded brain section and mounted on poly-L
lysine coated slides. Prior to any treatment, sections were
de-waxed in xylene and re-hydrated in graded ethanol/water
solutions.
In situ hybridisation
In situ hybridisation was carried out using digoxigenin (dig;
Roche, Lewes, UK) labelled single stranded DNA probes
and the Omnislide hybridisation system (Thermo Fisher
Scientific, MA, USA). A cocktail of either three probes
normal to or three probes complementary with SIV tran-
scripts were used within the hybridisation mix as described
previously (Canto-Nogues et al. 2001). After extensive
washing, bound probes were detected using an alkaline
phosphatise/BCIP/NBT chromagenic reaction (Roche,
Lewes, UK) for 2 h at room temperature (Ferguson et al.
2007). Sections were washed, counter stained with neutral
red, air-dried and mounted in Loctite Super Glue (Denton
1987). Quantification of ISH positive cells was performed
by manually counting all positive cells within up to 10
random fields of view (×10 lens and ×10 eyepiece magnifi-
cation; equivalent to 2.2 mm
2) and data calculated as the
mean number of positive cells per mm
2. Tabulated results
reflect the means score of all animals within that group.
Immunohistochemistry
Immunohistochemical analyses were performed as previ-
ously described (Ferguson et al. 2007). Unmasking of anti-
gens to allow binding of the antibody was undertaken by the
optimal technique for each combination of antibody and
antigen. Sections were incubated in 50 μgm L
−1 proteinase
K (Roche, Lewes, UK) in PBS pH 7.4 for 15 min at 37°C
prior to immunolabelling with CD3, CD8 (C8/144B), CD68
(KP1), GFAP (astrocytes), CD163 (GH1/61; Santa Cruz
Biotechnology Inc, California, USA) and CCR5 (3A9; Phar-
mingen, Oxford, UK). Sections were heated at full power
(800 W) for 5 min fully immersed in Vector unmasking
solution (Vector Laboratories, Peterborough, UK) previous-
ly heated to 96°C for immunolabelling of CD4 (H370, Santa
Cruz, Autogen Bioclear, Wiltshire), CNPase1 (oligodendro-
cytes, 11-5B) (Neomarkers), FF1 (phosphorylated neurofila-
ments, Dr E Gardner, William Paterson University, USA) or
10 mM citrate buffer (pH 6), KK41 (SIV gp41, Kent et al.
1991), KK75 (SIV Nef, Arnold et al. 1999). Sections were
treated using a MenaPath pressurised antigen access unit
(125°C 30 s, 90°C 10 s, Access Super solution) for immu-
nolabelling with iba-1 (microglia; Menarini Diagnostics).
MHC II staining (CR3/34; DAKO, Ely, Cambridgeshire,
UK) was performed on a BondMax automated staining
module (Leica Microsystems, USA) using a 30-min HIER1
unmasking protocol and Bond Polymer Refine staining
system.
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rienced assessors and tabulated results generated for the
means score of all animals within that group.
Results
Analysis of viral replication in vivo
Following inoculation of group A with SIVmacC8 and
group B with SIVmacJ5 SIV RNA was detected in plasma
collected at day 14 post challenge (Table 1). The log10 mean
viral loads were 4.04±0.55 for group A and 5.27±0.66 for
group B. Diagnostic PCR on DNA purified from blood
collected at this time confirmed that all macaques were
infected (Table 1). On the day of inoculation of
SIVmac17E-Fr, 20 weeks after inoculation of the first virus,
log10 mean SIV viral loads were 2.38±0.90 for group A and
2.67±1.32 for group B. At week 22 of the study (14dpc),
log10 mean viral loads for group A were 2.13±0.7, group B
2.55±1.4 and for group C 4.73±0.43. At week 43 of the
study (23wpc), when all macaques were killed humanely,
the mean log10 viral loads for group A were 1.93±0.83,
group B 2.33±1.4 and for group C ≤1.3±0.00
Differential DNA PCR analysis of blood cells collected
following SIVmac17E-Fr challenge detected the presence of
SIVmacC8 only in group A, SIVmacJ5 only in group B and
SIVmac17E-Fr only in group C macaques.
Haematological parameters
The proportion of CD3
+/CD4
+ and CD3
+/CD8
+ T cells and
platelet levels (×10
9/L) were determined at specific times
throughout the study. These data are presented in Table 2.
Prior to virus challenge the mean CD3
+/CD4
+ lymphocytes
for group A were 44.1%±5.9%, CD3
+/CD8
+ lymphocytes
were 20.5%±2.2% and platelet levels 400×10
9/L±70×10
9/
L. For group B CD3
+/CD4
+ lymphocytes were 44.9%±
3.5%, CD3
+/CD8
+ lymphocytes were 25.9%±6.8% and
platelet levels 422×10
9/L±62×10
9/L. For group A 14dp
SIVmacC8 challenge the mean CD3
+/CD4
+ lymphocytes
were 34.2%±10.3% and the mean CD3
+/CD8
+ lymphocytes
were 23.6%±8.8%. For group B 14dp SIVmacJ5 challenge
the mean CD3
+/CD4
+ lymphocytes were 35.5%±4.0% and
the mean CD3
+/CD8
+ lymphocytes were 32.7%±2.1%.
On the day of inoculation of SIVmac17E-Fr, 20 weeks
after inoculation of the first virus, the mean proportion in
group A of CD3
+/CD4
+ lymphocytes were 35.4%±8.6%,
CD3
+/CD8
+ lymphocytes were 19.7%±7.7% and platelet
levels 320×10
9/L±70×10
9/L. For group B the mean pro-
portion of CD3
+/CD4
+ lymphocytes were 33.9%±5.6%,
CD3
+/CD8
+ lymphocytes were 28.7%±3.2% and platelet
levels 374×10
9/L±61×10
9/L.
At week 22 of the study the mean proportion in group A
of CD3
+/CD4
+ lymphocytes were 34.1%±14.7%, CD3
+/
CD8
+ lymphocytes were 20.1%±11.5% and platelet levels
374×10
9/L±65×10
9/L. For group B the mean proportion of
CD3
+/CD4
+ lymphocytes were 39.8%±3.1%, CD3
+/CD8
+
lymphocytes were 28.1%±5.7% and platelet levels 382×
10
9/L±48×10
9/L. For group C the mean proportion of
CD3
+/CD4
+ lymphocytes were 35.7%±9.5%, CD3
+/CD8
+
lymphocytes were 18.6%±2.6% and platelet levels 259×
10
9/L±75×10
9/L. At week 43 of the study, when all mac-
aques were killed humanely, the mean proportion in group
A of CD3
+/CD4
+ lymphocytes were 44.5%±8.2%, the mean
proportion of CD3
+/CD8
+ lymphocytes were 19.4%±5.7%
and platelet levels 324×10
9/L±62×10
9/L. For group B
the mean proportion of CD3
+/CD4
+ lymphocytes were
33.8%±5.3%, the mean proportion of CD3
+/CD8
+ lympho-
cytes were 31.9%±10.8% and platelet levels 328×10
9/L±
179×10
9/L. For group C the mean proportion of CD3
+/
CD4
+ lymphocytes were 38.1%±6.1%, the mean proportion
of CD3
+/CD8
+ lymphocytes were 26.3%±3.6% and platelet
levels 277×10
9/L±53×10
9/L.
Viral detection within the CNS
SIV naïve macaques were negative for SIV by all viral
detection methods used. SIV replication was detected in
brain tissue by in situ hybridisation in all animals challenged
with SIV (Table 3, Fig. 1). Immunohistochemical analyses
detected the presence of SIVenvelope (anti-gp41; KK41) in
tissues from all SIV-infected macaques. However immuno-
labelling with the anti-SIV Nef antibody (KK75) detected
signals only in macaques infected with SIVmacC8 and
SIVmacJ5 (Table 3, Fig. 1).
Pathological changes to the brain following SIV infection
Brain sections of SIV naive macaques showed expression of
GFAP (astrocytes), CNPase1 (oligodendrocytes) and FF1
(phosphorylated neurofilaments) across the white matter of
all sections. Little alteration in expression levels of CNPase1
or FF1 was noted in brain sections from SIVmacC8-infected
animals, whereas the intensity of staining for GFAP was
markedly increased (Table 4, Fig. 2). Following infection
with SIVmacJ5 or SIVmac17E-Fr there were alterations in
expression levels of all three markers. Brain sections from
SIVmacJ5-infected animals exhibited an increase in the
intensity of GFAP expression, particularly in the cerebrum,
midbrain and cerebellum. By contrast, CNPase1 and FF1
expression were reduced in these areas (Table 4, Fig. 2).
Infection with SIVmac17E-Fr resulted in an increase in the
intensity of GFAP staining (Table 4,F i g .2), whereas
CNPase1 and FF1 expression levels were greatly reduced
across all tissue regions.
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104 J. Neurovirol. (2012) 18:100–112Analysis of the expression of the macrophage marker
CD68 revealed an increased intensity of staining in all
SIV-infected animals. The greatest increase was observed
within the midbrain and brain stem of SIVmacJ5-infected
macaques and cerebrum, brain stem and cerebellum of
SIVmac17E-Fr-infected macaques (Table 4, Fig. 3).
Analysis of the expression of the microglial marker iba-1
revealed low numbers of pale stained cell bodies and pro-
cesses in SIV naive animals (Table 4, Fig. 3). SIV-infected
tissue exhibited cells where both round cell bodies and
extended processes were more strongly stained. Expression
levels of iba-1 were moderate in SIVmacC8-infected tissues
in which cellular bodies with numerous cellular ramifica-
tions were stained. SIVmacJ5-infected tissues contained
numerous strongly stained cellular bodies however the
strongly stained cellular processes appeared truncated. The
highest iba-1 expression levels were observed within
SIVmac17E-Fr-infected tissues where large numbers of
intensely stained cell bodies and processes were found.
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1 Table 3 Viral replication in the different sections of the brain
In situ hybridisation Env (gp41) nef Expression
Naïve Macaque
Cerebrum −ve −ve −ve
Midbrain −ve −ve −ve
Brain Stem −ve −ve −ve
Cerebellum −ve −ve −ve
SIVmacC8
Cerebrum +
i ++
Midbrain +
i ++
Brain Stem +
i ++
Cerebellum +
i ++
SIVmacJ5
Cerebrum +
i ++
Midbrain +
i ++
Brain Stem +
i ++
Cerebellum +
i ++
SIVmac17E-Fr
Cerebrum +
i + −ve
Midbrain +
i + −ve
Brain Stem +
i + −ve
Cerebellum +
i + −ve
Evidence of viral replication was shown by in situ hybridisation to
detect viral RNA, gp41 (envelope protein) to show evidence of virion
assembly, and nef expression to identify productively infected cells.
Cerebrum 0 frontal, parietal, occipital, and temporal lobe sections;
Midbrain 0 thalamus and midbrain sections; Brain stem 0 pons and
medulla oblongata sections; Cerebellum 0 cerebellum. +
i ISH positive
cells present between 0.5 and 6.8+ve cells/mm
2. + Immunoreactive
cells identified in all sections examined. −ve No immunoreactive cells
identified
J. Neurovirol. (2012) 18:100–112 105In addition, strongly stained amoeboid cells lacking any
cellular processes were found scattered through the tissues
(Table 4, Fig. 3).
Expression of the macrophage marker CD163 was not
detected within brain tissue samples from SIV naive mac-
aques. The cerebrum and midbrain of SIVmacC8-infected
macaques exhibited low frequencies of CD163 positive cells
associated with capillary vessels whereas this marker was
detected with increasing frequency through SIVmacJ5 and
SIVmac17E-Fr-infected tissues (Table 4, Fig. 3).
MHC class IIexpressionwas detectedonsmall numbers of
perivascular macrophage within all tissue sections from SIV
naive macaques and all areas showed strong expression of the
chemokine receptor CCR5, notably on neurones within the
cerebral cortex and Purkinje cells within the cerebellum
(Table 5,F i g .4). Foci of increased MHCII expression
within perivascular macrophage were observed follow-
i n gi n f e c t i o nw i t he i t h e rS I V m a c J 5o rS I V m a c 1 7 E - F r .
MHCII expression was not observed within migroglia.
MHC class II expression levels in SIVmacC8-infected
a  c  b 
Fig. 1 Representative images from frontal lobe showing results obtained following either SIVmacJ5 (a, c) or SIVmac17E-Fr (b) infection for a in
situ hybridisation (×40), b anti-SIV env (×40) and c anti-SIV nef (×40)
Table 4 Pathological changes to the macaque brain following infection with SIV
Macrophage
(CD68)
Microglia
(iba-1)
Infected Microglia
(CD163)
Astrocyte
(GFAP)
Oligodendrocyte
(CNPase1)
Neuron
(FF1)
Naïve Macaque
Cerebrum + + –ve + +++ +++
Midbrain + + –ve + +++ ++
Brain Stem + + –ve + +++ ++
Cerebellum –ve + –ve + +++ ++
SIVmacC8
Cerebrum ++ ++ + +++ +++ +++
Midbrain + ++ + +++ +++ ++
Brain Stem + +++ −ve +++ +++ ++
Cerebellum + ++ −ve +++ +++ ++
SIVmacJ5
Cerebrum + +++ ++ ++ ++ ++
Midbrain ++ +++ + ++ ++ +
Brain Stem ++ +++ + +++ +++ ++
Cerebellum + ++ + ++ ++ +
SIVmac17E-Fr
Cerebrum ++ ++++ ++ ++ + +
Midbrain + ++++ ++ ++ ++ +
Brain Stem ++ ++++ + ++ ++ +
Cerebellum ++ +++ + ++ + +
Macaques were infected with either SIVmacC8, SIVmacJ5, or SIVmac17E-Fr. Sections from the brain were examined for alterations to microglia,
astrocytes, oligodendrocytes and neurones. Cerebrum 0 frontal, parietal, occipital, and temporal lobe sections; Midbrain 0 thalamus and midbrain
sections; Brain stem 0 pons and medulla oblongata sections; Cerebellum 0 cerebellum. ++++ Very strong immunoreactive staining in all sections
examined. +++ Strong immunoreactive staining in all sections examined. ++ Moderate immunoreactive staining in all sections examined. + Weak
immunoreactive staining in all sections examined. –ve No immunoreactive staining identified
106 J. Neurovirol. (2012) 18:100–112tissue were equivalent to those observed in SIV naive
tissues (Table 5,F i g .4). Following SIVmacC8 or SIV-
macJ5 infection tissues showed an equal level of reduc-
tion of CCR5 expression in the midbrain, brain stem
and cerebellum (Table 5,F i g .4). Within SIVmac17E-Fr-
infected tissues CCR5 expression levels were further
reduced within the cerebrum and brain stem (Table 5).
Low frequencies of CD3
+ T cells were detected in brain
tissues from all animals. There were no observable differ-
ences between the four groups (Table 5).
Similar levels of CD8
+ T cells were detectable in the
cerebrum, midbrain and cerebellum of all SIV-infected ani-
mals whereas CD4+ T cells were only detected in the
cerebrum of SIVmacJ5 or SIVmac17E-Fr-infected animals
(Table 5).
Discussion
The initiation and development of the neuropathology that
leads to either HAND or HAD remains unclear whilst the
daily impact on patients and healthcare systems continues
despite advances in ART (Ellis et al. 2007; Valcour et al.
2011; Letendre et al. 2010).
Accelerated models of SIV infection within rhesus mac-
aques has been used extensively to model largely late stage
HIV-associated pathology of the brain and central nervous
system (Babas et al. 2003; Flaherty et al. 1997; Orandle et
al. 2002: Overholser et al. 2003; Williams et al. 2001)B y
contrast, the CNS pathology induced following SIV infec-
tion of cynomolgus macaques (Macaca fascicularis) pro-
gressing at a natural rate has not been extensively described.
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Fig. 2 Representativeimagesshowingimmunohistochemicalstainingresultsfora–dastrocytes(GFAP×10),e–holigodendrocytes(CNPase1×10)and
i–l neuronal phosphorylation (FF-1×20) within a–h frontal lobe and i–l cerebellum of either SIV naive or SIV-infected brain samples
J. Neurovirol. (2012) 18:100–112 107The design of a vaccine study provided an opportunity to
investigate the neuropathogenic potential of viruses with
very different biological characteristics (Clarke et al. 2003;
Berry et al. 2008) during a timeframe when peripheral levels
of viral replication were minimal and there was no evidence
of peripheral disease progression. Despite extensive analysis
of PBMC and lymphoid tissues no evidence of SIVmac17E-
Fr super infection was found within groups A and B enabling
the neuropathology induced by the T cell tropic SIV clones
SIVmacC8 and SIVmacJ5 to be determined. These results
were analysed in the context of the increased rate of neuropa-
thologydevelopmentobservedwithincymomolgusmacaques
infected by the known neurotropic SIVmac17E-fr.
The development of neuropathology in cynomolgus mac-
aques following SIV infection has been reported for a small
number of animals only (Baskerville et al. 1990; Li et al.
1991; Mankowski et al. 1997; Zink et al. 1997) and the
development of a severe neuropathology was not commonly
found. This study extends this knowledge within a non-
accelerated model for SIVmac17E-Fr (Flaherty et al. 1997)
that has been used extensively in rhesus macaques because
of its defined neurovirulence and SIVmacJ5 and SIV-
macC8; molecular clones derived from the 32H re-isolate
of SIVmac251. In vitro data indicates these clones are Tcell
tropic, (Rud et al. 1994). Furthermore, whilst SIVmacJ5 and
SIVmacC8 are isogenic, SIVmacC8 expresses an attenuated
phenotype in vivo as a result of a small in frame deletion in
nef (Rud et al. 1994; Almond et al. 1995).
Despite SIVmac17E-Fr exhibiting a readily and effec-
tively controlled primary viremia within cynomolgus
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Fig. 3 Representative images showing immunohistochemical staining results for a–d macrophage (CD68, ×40), E-H: microglia (iba-1, ×20), and
i–l SIV-infected microglia (CD163, ×40) within frontal lobe of either SIV naive or SIV-infected brain samples
108 J. Neurovirol. (2012) 18:100–112macaques the detection of virus-infected cells within these
brains was not unexpected due to the known neurotropic
properties of SIVmac17E-Fr in rhesus and pig-tail macaques
(Zinketal.1997).TherewaslesscertaintywhetherSIVmacJ5
would be detected within this timeframe (Montgomery et al.
1998, 1999). Even more unexpected was the detection of the
attenuated SIVmacC8 in the brain at a time when only low
levels of virus were detected in the circulation by RT-PCR. If
free virus is involved in neuro-invasion then, in cyno-
molgus macaques at least, it must occur during the early
viremic phase. If this is the case it would indicate that
clinical management of HIV neurological complications
may need to take account of events that occur early
after infection.
If, as it would appear, non neurotropic SIV is able to
establish infection in neurological tissue relatively soon
after infection, then where does it replicate? Many studies
have identified cells of the monocyte macrophage lineage as
being the major cell types infected following HIV or SIV
infection of the brain (Albright et al. 2000;K o l s o na n d
Gonzalez-Scarano 2000; Clements et al. 2002; Cosenza et
al. 2002; Gonzalez-Scarano et al. 2005).
The results using CD68 and CD163 indicate that follow-
ing SIV infection expression levels are increased 43 weeks
post SIVmacJ5 or SIVmacC8 challenge with the highest
expression levels being found 23 weeks post SIVmac17E-
Fr infection. Due to the morphology, tissue position, expres-
sion levels and disease state of the animals, it is likely that
the cells expressing these markers are perivascular macro-
phage. CD163 staining of ramified activated microglia has
currently only been reported in conjunction with SIV
encephalitis (SIVE; Borda et al. 2008; Kim et al. 2006)
and the likely activation, via CD163, following vascular
leakage of Hp–Hb complexes through a damaged BBB.
As a damaged BBB is a potential route of viral entry
early in infection, it is unclear why microglial activation
via CD163 is not present prior to the development of
SIVE. A detailed examination of the timing of BBB
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Fig. 4 Representative images showing immunohistochemical staining
results for a–d MHCII (×20) and e–h CCR5 (×20); a–d frontal lobe
and e–h cerebellum of either SIV naive or SIV-infected brain samples
Table 5 Immunological response to viral replication
T-cell MHC II CCR5
Naïve Macaque
Cerebrum + (CD3
+) + +++
Midbrain + (CD3
+) + +++
Brain Stem + (CD3
+) + +++
Cerebellum + (CD3
+) + +++
SIVmacC8
Cerebrum + (CD3
+, CD8
+) + +++
Midbrain + (CD3
+, CD8
+)+ + +
Brain Stem + (CD3
+)+ + +
Cerebellum + (CD3
+, CD8
+)+ + +
SIVmacJ5
Cerebrum + (CD3
+, CD4
+, CD8
+) ++ +++
Midbrain + (CD3
+, CD8
+)+ + + +
Brain Stem + (CD3
+)+ + + +
Cerebellum + (CD3
+, CD8
+)+ + + +
SIVmac17E-Fr
Cerebrum + (CD3
+, CD4
+, CD8
+)+ + +
Midbrain + (CD3
+, CD8
+)+ + + +
Brain Stem + (CD3
+)+ + +
Cerebellum + (CD3
+, CD8
+)+ + + +
Macaques were infected with either SIVmacC8, SIVmacJ5, or
SIVmac17E-Fr. Sections from the brain were examined for T-cell
proliferation, MHC class II expression and CCR5 expression. Cere-
brum 0 frontal, parietal, occipital, and temporal lobe sections; Mid-
brain 0 thalamus and midbrain sections; Brain stem 0 pons and
medulla oblongata sections; Cerebellum 0 cerebellum. ++++ Very
strong immunoreactive staining in all sections examined. +++ Strong
immunoreactive staining in all sections examined. ++ Moderate
immunoreactive staining in all sections examined. + Weak immu-
noreactive staining in all sections examined. −ve No immunore-
active staining identified
J. Neurovirol. (2012) 18:100–112 109disruption following SIV infection would provide further
information for this debate.
The infiltration of T cells, especially CD8
+ T cells, into
the CNS following infection clearly indicates there had been
disruption of the blood brain barrier at some point(s) during
infection (Table 5). T cells are normally excluded from the
brain, although they are known to cross the BBB during
periods of neuroinflammation (Ballabh et al. 2004). SIV
infection of rhesus macaques has been shown to disrupt
lengths of the BBB (Luabeya et al. 2000; Maclean et al.
2005), as has HIV infection of humans (Annunziata 2003).
Vascular leakage and subsequent inflammatory changes
may explain the neuropathology identified. A longitudinal
study with particular focus on the integrity of the BBB and
inflammatory markers at various stages following SIV in-
fection would provide further information regarding the
aetiology and subsequent development of SIV associated
neuropathology within cynomolgus macaques.
Microglial cells are considered to have an important role
in SIV associated neuropathology. Within the brain, iba-1
has been shown to be expressed by resting microglia, with
expression levels up-regulated following microglial activa-
tion (Imai et al. 1996). Levels of neuropathological iba-1
expression following SIVinfection have not been extensively
reported and, where they have, microglial expression levels
have been shown to increase following CD8 depletion of
SIVmac251-infected rhesus macaques (Ratai et al. 2010)
and within microglia surrounding SIVE lesions in
SIVmac239-infected rhesus (Borda et al. 2008). Similar to
the results of Borda et al. (2008), we observed iba-1 staining
of resting ramified microglia within brain tissue of SIV naive
macaques.
Infection with either the nef attenuated SIVmacC8 or
SIVmacJ5 increased iba-1 expression levels within micro-
glial cell bodies and cytoplasmic processes with these pro-
cesses being shortened in SIVmacJ5-infected tissue.
Microglia within SIVmac17E-Fr-infected tissues expressed
the highest levels of iba-1 notably also on microglia with an
amoeboid morphology. The differential microglial morphol-
ogies observed may reflect transition between a ramified
resting state and activated amoeboid state with this triggered
most rapidly by neurotropic viral strains. That there are
various stages of transition before full activation may be
reflected in the lack of MHCII expression observed on
microglia within infected tissues. MHCII expression was
observed within an increasing numbers of foci of perivas-
cular macrophage.
Previous studies have observed oligodendrocyte degra-
dation and demyelination following SIV infection of rhesus
macaques (Pope et al. 1997; Chretien et al. 2000; Marcario
et al. 2004; Roberts 2005). This study found significant loss
of CNPase1 expression within the white matter of cynomol-
gus macaques following SIVmac17E-Fr infection, with
SIVmacJ5 infection reducing expression levels to a lesser
extent. However following SIVmacC8 infection, CNPase1
expression levels were comparable with those observed in
SIV naïve macaques further highlighting the differential
pathology induced at this time point by a nef attenuated SIV.
Neurofilaments are highly phosphorylated structural pro-
teins involved in the transfer of material from the cell body
to the axonal foot (Lariviere and Julien 2004). HIV gp120
and tat induces neurofilament damage in tissue culture (Kaul
and Lipton 1999; Ramirez et al. 2001) and within rhesus
macaques infected with neurovirulent SIV (Adamson et al.
1996). This study demonstrates the ability of a neurovirulent
SIV to alter neurofilament phosphorylation levels within
cynomolgus macaques relatively early during the infection
process and that this effect is also induced by wild-type
lymphatropic SIV strains albeit at a slower rate. Neuronal
effects of SIV infection were further observed by the loss of
CCR5 expression by neuronal cell bodies within both the
cerebrum and cerebellum. As SIVor HIVinfection of neuro-
nes have not been demonstrated these neuronal effects may
result from direct binding of viral proteins such as gp120 or
Tat (Jones and Power 2006).
Whilst accelerated neurovirulent SIV/rhesus macaque
models of HIV neuropathology provide a platform to study
late stage disease relatively few studies have addressed its
aetiology, notably early CNS invasion events and the sub-
sequent pathologies that develop despite a controlled
peripheral viremia. The availability of a model to investigate
these areas is required to address many questions including
what role persisting low level viral replication and/or viral
protein/RNA expression plays in driving the development of
neuropathology, can new therapeutic targets be identified,
what are the neurological benefits of CNS penetrating thera-
piesandhowthisinformationcanbeusedtoinformthedebate
regarding clinical use of early treatment for neurological ben-
efit. Future studies investigating both tissue samples and
matched CSF samples from this time frame could assist the
identification of early peripheral markers of neuro-AIDS.
The changes observed within this study using standard
neuropathology markers demonstrate that non-accelerated
infections of cynomolgus macaques with SIV, including
isolates not immediately recognised as neurotropic, can
induce differential patterns of CNS pathologies. These
are present despite limited peripheral viral replication or
evidence of disease progression and develop at different
rates. The range of pathologies observed potentially
reflects different points on the spectrum of HIV clinical
neuropathological patterns requiring treatment and
healthcare support (Ellis et al. 2007; Lindl et al. 2010;
Valcour et al. 2011).
Further studies of the early neuropathogenesis in cyno-
molgus macaques may provide information on a number of
important questions such as when and how different virus
110 J. Neurovirol. (2012) 18:100–112strains enter the CNS and what tissue responses occur. Most
important is the opportunity to use these simian models to
define the role of ongoing virus replication on BBB integ-
rity, inflammatory responses and subsequent pathological
events. This will inform whether early intervention tailored
to neurological events rather that treatment for late stage
peripheral disease is beneficial in slowing or even stopping
the development of a deleterious neuropathology.
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